376 related articles for article (PubMed ID: 14726483)
21. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B.
Blanchette M; Chabot B
RNA; 1997 Apr; 3(4):405-19. PubMed ID: 9085847
[TBL] [Abstract][Full Text] [Related]
22. Terminal antisense oligonucleotide modifications can enhance induced exon skipping.
Gebski BL; Errington SJ; Johnsen RD; Fletcher S; Wilton SD
Neuromuscul Disord; 2005 Oct; 15(9-10):622-9. PubMed ID: 16084084
[TBL] [Abstract][Full Text] [Related]
23. Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion.
Zhou H
Methods Mol Biol; 2022; 2434():53-62. PubMed ID: 35213009
[TBL] [Abstract][Full Text] [Related]
24. Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
Sazani P; Astriab-Fischer A; Kole R
Antisense Nucleic Acid Drug Dev; 2003; 13(3):119-28. PubMed ID: 12954112
[TBL] [Abstract][Full Text] [Related]
25. Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.
Kang SH; Zirbes EL; Kole R
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):497-505. PubMed ID: 10645775
[TBL] [Abstract][Full Text] [Related]
26. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
27. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice.
Roberts J; Palma E; Sazani P; Ørum H; Cho M; Kole R
Mol Ther; 2006 Oct; 14(4):471-5. PubMed ID: 16854630
[TBL] [Abstract][Full Text] [Related]
28. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
[TBL] [Abstract][Full Text] [Related]
29. Direct isolation of poly(A)+ RNA from 4 M guanidine thiocyanate-lysed cell extracts using locked nucleic acid-oligo(T) capture.
Jacobsen N; Nielsen PS; Jeffares DC; Eriksen J; Ohlsson H; Arctander P; Kauppinen S
Nucleic Acids Res; 2004 Apr; 32(7):e64. PubMed ID: 15096560
[TBL] [Abstract][Full Text] [Related]
30. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753
[TBL] [Abstract][Full Text] [Related]
31. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of splice sites to antisense oligonucleotides in vivo.
Sierakowska H; Sambade MJ; Schümperli D; Kole R
RNA; 1999 Mar; 5(3):369-77. PubMed ID: 10094306
[TBL] [Abstract][Full Text] [Related]
33. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatitis B virus (HBV) by LNA-mediated nuclear interference with HBV DNA transcription.
Sun Z; Xiang W; Guo Y; Chen Z; Liu W; Lu D
Biochem Biophys Res Commun; 2011 Jun; 409(3):430-5. PubMed ID: 21596023
[TBL] [Abstract][Full Text] [Related]
35. Antisense effects in the cell nucleus: modification of splicing.
Kole R; Sazani P
Curr Opin Mol Ther; 2001 Jun; 3(3):229-34. PubMed ID: 11497345
[TBL] [Abstract][Full Text] [Related]
36. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
37. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
38. LNA and alpha-L-LNA: towards therapeutic applications.
Wengel J; Vester B; Lundberg LB; Douthwaite S; Sørensen MD; Babu BR; Gait MJ; Arzumanov A; Petersen M; Nielsen JT
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):601-4. PubMed ID: 14565236
[TBL] [Abstract][Full Text] [Related]
39. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.
Aartsma-Rus A; Kaman WE; Bremmer-Bout M; Janson AA; den Dunnen JT; van Ommen GJ; van Deutekom JC
Gene Ther; 2004 Sep; 11(18):1391-8. PubMed ID: 15229633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]